Drug Trial Radar · NCT03653520
Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron)
Last checked: Nov 19, 2026Latest source record: Aug 31, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
651
Actual
Start
Jun 28, 2017
Primary completion
Nov 2, 2017
Study completion Nov 4, 2017
Sponsor
- Lead sponsor
- Avanti AnesthesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 31, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The investigators hypothesized that the combination of Valium, Tramadol and Zofran is superior to the substantially more expensive MKO melt in patient satisfaction after cataract surgery.
Conditions
- Cataract
Interventions
DiazepamDrug
5 or 10mg
TramadolDrug
50mg or 100mg
OndansetronDrug
1 or two tabs
MKO meltDrug
1 or 2 MKO melts
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patient who needed additional IV medication for cataract surgeryTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Memorial Hermann Kirby Glen Surgery Center
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.